Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SGLT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SGLT2 |
| Key Genes/Proteins | FUNDC1, HK2, HMGCS2, LDH, mTOR, MTOR |
| Related Diseases | neurodegeneration, Parkinson's disease |
| Related Pathways | ferroptosis, lipid metabolism, oxidative stress response |
Knowledge base pages for this entity
graph TD
SGLT2[SGLT2]
SGLT2 -->|regulates| Glucose_Reabsorption[Glucose Reabsorption]
SGLT2 -.biomarker for.-> type_2_diabetes[type 2 diabetes]
SGLT2 -->|involved_in| glucose_metabolism[glucose metabolism]
SGLT2 -->|regulates| MTOR[MTOR]
SGLT2 -->|regulates| mTOR[mTOR]
SGLT2 -->|participates in| ferroptosis[ferroptosis]
SGLT2 -->|inhibits| VDAC1[VDAC1]
SGLT2 -->|inhibits| neurodegeneration[neurodegeneration]
SGLT2 -->|participates in| oxidative_stress_response[oxidative stress response]
SGLT2 -->|participates in| lipid_metabolism[lipid metabolism]
Gliflozins[Gliflozins] -->|inhibits| SGLT2
Glucose[Glucose] -->|upregulates| SGLT2
HK2[HK2] -->|activates| SGLT2
LDH[LDH] -->|activates| SGLT2
PGC1A[PGC1A] -->|activates| SGLT2
PLIN2[PLIN2] -->|activates| SGLT2
PPARA[PPARA] -->|activates| SGLT2
FUNDC1[FUNDC1] -->|inhibits| SGLT2| Target | Relation | Type | Str |
|---|---|---|---|
| Glucose Reabsorption | regulates | process | 0.95 |
| glucose metabolism | involved_in | process | 0.90 |
| type 2 diabetes | biomarker_for | disease | 0.90 |
| MTOR | regulates | protein | 0.70 |
| mTOR | regulates | protein | 0.70 |
| oxidative stress response | participates_in | pathway | 0.60 |
| lipid metabolism | participates_in | pathway | 0.60 |
| neurodegeneration | inhibits | disease | 0.60 |
| ferroptosis | participates_in | pathway | 0.60 |
| VDAC1 | inhibits | gene | 0.60 |
| senescence | participates_in | pathway | 0.60 |
| Parkinson's disease | inhibits | disease | 0.60 |
| stem cells | expressed_in | cell_type | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SGLT2 in their description or question text
No additional research found